Reduced Atherosclerosis in ApoE-inhibitory FcγRIIb-Deficient Mice Is Associated With Increased Anti-Inflammatory Responses by T Cells and Macrophages
Overview
Affiliations
Objective: Fcγ receptors (FcγRs) are classified as activating (FcγRI, III, and IV) and inhibitory (FcγRII) receptors. We have reported that deletion of activating FcγRs in apolipoprotein E (apoE) single knockout mice attenuated atherosclerosis. In this report, we investigated the hypothesis that deficiency of inhibitory FcγRIIb exacerbates atherosclerosis.
Approach And Results: ApoE-FcγRIIb double knockout mice, congenic to the C57BL/6 (apoE-FcγRIIbB6 (-/-)), were generated and atherosclerotic lesions were assessed. In contrary to our hypothesis, when compared with apoE single knockout mice, arterial lesions were significantly decreased in apoE-FcγRIIbB6 (-/-) male and female mice fed chow or high-fat diets. Chimeric mice generated by transplanting apoE-FcγRIIbB6 (-/-) marrow into apoE single knockout mice also developed reduced lesions. CD4(+) T cells from apoE-FcγRIIbB6 (-/-) mice produced higher levels of interleukin-10 and transforming growth factor-β than their apoE single knockout counterparts. As our findings conflict with a previous report using apoE-FcγRIIb129/B6 (-/-) mice on a mixed genetic background, we investigated whether strain differences contributed to the anti-inflammatory response. Macrophages from FcγRIIb129/B6 (-/-) mice on a mixed genetic background produced more interleukin-1β and MCP-1 (monocyte chemoattractant protein-1) in response to immune complexes, whereas congenic FcγRIIbB6 (-/-) mice generated more interleukin-10 and significantly less interleukin-1β. Interestingly, the expression of lupus-associated slam genes, located in proximity to fcgr2b in mouse chromosome 1, is upregulated only in mixed FcγRIIb129/B6 (-/-) mice.
Conclusions: Our findings demonstrate a detrimental role for FcγRIIb signaling in atherosclerosis and the contribution of anti-inflammatory cytokine responses in the attenuated lesions observed in apoE-FcγRIIbB6 (-/-) mice. As 129/sv genome-derived lupus-associated genes have been implicated in lupus phenotype in FcγRIIb129/B6 (-/-) mice, our findings suggest possible epistatic mechanism contributing to the decreased lesions.
Atherosclerosis antigens as targets for immunotherapy.
Raposo-Gutierrez I, Rodriguez-Ronchel A, Ramiro A Nat Cardiovasc Res. 2024; 2(12):1129-1147.
PMID: 39196152 DOI: 10.1038/s44161-023-00376-x.
Fcα Receptor Type I and Its Association with Atherosclerosis Development.
Desaki Y, Kanamaru Y, Monteiro R, Suzuki Y Juntendo Iji Zasshi. 2024; 69(3):231-239.
PMID: 38855431 PMC: 11153080. DOI: 10.14789/jmj.JMJ23-0003-OA.
Antibodies in action: the role of humoral immunity in the fight against atherosclerosis.
Taylor J, Hutchinson M, Gearhart P, Maul R Immun Ageing. 2022; 19(1):59.
PMID: 36461105 PMC: 9717479. DOI: 10.1186/s12979-022-00316-6.
Auto-Antibody Production During Experimental Atherosclerosis in Mice.
Hutchinson M, Park H, Zanotti K, Alvarez-Gonzalez J, Zhang J, Zhang L Front Immunol. 2021; 12:695220.
PMID: 34305930 PMC: 8299997. DOI: 10.3389/fimmu.2021.695220.
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.
Gopal R, Marinelli M, Alcorn J Front Immunol. 2020; 11:570681.
PMID: 33193350 PMC: 7642610. DOI: 10.3389/fimmu.2020.570681.